JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: BI-D1870 is a specific, cell permeable and ATP-competitive inhibitor of RSK1/2/3/4 (p90 ribosomal S6 kinase) with the potential to treat autoimmune encephalomyelitis (EAE). It inhibits RSK1/2/3/4 with IC50s of 31 nM/24 nM/18 nM/15 nM in cell-free assays, respectively. and displays 10- to 100-fold higher selectivity for RSK over MST2, GSK-3beta, MARK3, CK1 and Aurora B. RSKs are serine/threonine kinases that are involved in various cellular processes including growth, survival, and motility. BI-D1870 also showed potent antiproliferative activity in vitro.
References: Biochem J. 2007 Jan 1; 401(Pt 1): 29–38.
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Recommend by mail
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!